Early Clinical Variables Associated With Refractory Convulsive Status Epilepticus in Children
© 2023 American Academy of Neurology..
BACKGROUND AND OBJECTIVES: The objective of this study was to determine patient-specific factors known proximate to the presentation to emergency care associated with the development of refractory convulsive status epilepticus (RSE) in children.
METHODS: An observational case-control study was conducted comparing pediatric patients (1 month-21 years) with convulsive SE whose seizures stopped after benzodiazepine (BZD) and a single second-line antiseizure medication (ASM) (responsive established status epilepticus [rESE]) with patients requiring more than a BZD and a single second-line ASM to stop their seizures (RSE). These subpopulations were obtained from the pediatric Status Epilepticus Research Group study cohort. We explored clinical variables that could be acquired early after presentation to emergency medical services with univariate analysis of the raw data. Variables with p < 0.1 were retained for univariable and multivariable regression analyses. Multivariable logistic regression models were fit to age-matched and sex-matched data to obtain variables associated with RSE.
RESULTS: We compared data from a total of 595 episodes of pediatric SE. Univariate analysis demonstrated no differences in time to the first BZD (RSE 16 minutes [IQR 5-45]; rESE 18 minutes [IQR 6-44], p = 0.068). Time to second-line ASM was shorter in patients with RSE (RSE 65 minutes; rESE 70 minutes; p = 0.021). Both univariable and multivariable regression analyses revealed a family history of seizures (OR 0.37; 95% CI 0.20-0.70, p = 0.0022) or a prescription for rectal diazepam (OR 0.21; 95% CI 0.078-0.53, p = 0.0012) was associated with decreased odds of RSE.
DISCUSSION: Time to initial BZD or second-line ASM was not associated with progression to RSE in our cohort of patients with rESE. A family history of seizures and a prescription for rectal diazepam were associated with a decreased likelihood of progression to RSE. Early attainment of these variables may help care for pediatric rESE in a more patient-tailored manner.
CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that patient and clinical factors may predict RSE in children with convulsive seizures.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:101 |
|---|---|
| Enthalten in: |
Neurology - 101(2023), 5 vom: 01. Aug., Seite e546-e557 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Peariso, Katrina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
12794-10-4 |
|---|
| Anmerkungen: |
Date Completed 02.08.2023 Date Revised 06.08.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1212/WNL.0000000000207472 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357977173 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357977173 | ||
| 003 | DE-627 | ||
| 005 | 20231226073746.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1212/WNL.0000000000207472 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1193.xml |
| 035 | |a (DE-627)NLM357977173 | ||
| 035 | |a (NLM)37295955 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Peariso, Katrina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Early Clinical Variables Associated With Refractory Convulsive Status Epilepticus in Children |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.08.2023 | ||
| 500 | |a Date Revised 06.08.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 American Academy of Neurology. | ||
| 520 | |a BACKGROUND AND OBJECTIVES: The objective of this study was to determine patient-specific factors known proximate to the presentation to emergency care associated with the development of refractory convulsive status epilepticus (RSE) in children | ||
| 520 | |a METHODS: An observational case-control study was conducted comparing pediatric patients (1 month-21 years) with convulsive SE whose seizures stopped after benzodiazepine (BZD) and a single second-line antiseizure medication (ASM) (responsive established status epilepticus [rESE]) with patients requiring more than a BZD and a single second-line ASM to stop their seizures (RSE). These subpopulations were obtained from the pediatric Status Epilepticus Research Group study cohort. We explored clinical variables that could be acquired early after presentation to emergency medical services with univariate analysis of the raw data. Variables with p < 0.1 were retained for univariable and multivariable regression analyses. Multivariable logistic regression models were fit to age-matched and sex-matched data to obtain variables associated with RSE | ||
| 520 | |a RESULTS: We compared data from a total of 595 episodes of pediatric SE. Univariate analysis demonstrated no differences in time to the first BZD (RSE 16 minutes [IQR 5-45]; rESE 18 minutes [IQR 6-44], p = 0.068). Time to second-line ASM was shorter in patients with RSE (RSE 65 minutes; rESE 70 minutes; p = 0.021). Both univariable and multivariable regression analyses revealed a family history of seizures (OR 0.37; 95% CI 0.20-0.70, p = 0.0022) or a prescription for rectal diazepam (OR 0.21; 95% CI 0.078-0.53, p = 0.0012) was associated with decreased odds of RSE | ||
| 520 | |a DISCUSSION: Time to initial BZD or second-line ASM was not associated with progression to RSE in our cohort of patients with rESE. A family history of seizures and a prescription for rectal diazepam were associated with a decreased likelihood of progression to RSE. Early attainment of these variables may help care for pediatric rESE in a more patient-tailored manner | ||
| 520 | |a CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that patient and clinical factors may predict RSE in children with convulsive seizures | ||
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 7 | |a Anticonvulsants |2 NLM | |
| 650 | 7 | |a Benzodiazepines |2 NLM | |
| 650 | 7 | |a 12794-10-4 |2 NLM | |
| 650 | 7 | |a Diazepam |2 NLM | |
| 650 | 7 | |a Q3JTX2Q7TU |2 NLM | |
| 700 | 1 | |a Arya, Ravindra |e verfasserin |4 aut | |
| 700 | 1 | |a Glauser, Tracy |e verfasserin |4 aut | |
| 700 | 1 | |a Abend, Nicholas S |e verfasserin |4 aut | |
| 700 | 1 | |a Barcia Aguilar, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Amengual-Gual, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Anderson, Anne |e verfasserin |4 aut | |
| 700 | 1 | |a Appavu, Brian L |e verfasserin |4 aut | |
| 700 | 1 | |a Brenton, J Nicholas |e verfasserin |4 aut | |
| 700 | 1 | |a Carpenter, Jessica |e verfasserin |4 aut | |
| 700 | 1 | |a Chapman, Kevin E |e verfasserin |4 aut | |
| 700 | 1 | |a Clark, Justice |e verfasserin |4 aut | |
| 700 | 1 | |a Gaillard, William D |e verfasserin |4 aut | |
| 700 | 1 | |a Gaínza-Lein, Marina |e verfasserin |4 aut | |
| 700 | 1 | |a Goldstein, Joshua |e verfasserin |4 aut | |
| 700 | 1 | |a Goodkin, Howard |e verfasserin |4 aut | |
| 700 | 1 | |a Grinspan, Zachary |e verfasserin |4 aut | |
| 700 | 1 | |a Guerriero, Rejean M |e verfasserin |4 aut | |
| 700 | 1 | |a Horn, Paul S |e verfasserin |4 aut | |
| 700 | 1 | |a Huh, Linda |e verfasserin |4 aut | |
| 700 | 1 | |a Kahoud, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Kelley, Sarah A |e verfasserin |4 aut | |
| 700 | 1 | |a Kossoff, Eric H |e verfasserin |4 aut | |
| 700 | 1 | |a Kapur, Kush |e verfasserin |4 aut | |
| 700 | 1 | |a Lai, Yi-Chen |e verfasserin |4 aut | |
| 700 | 1 | |a Marquis, B Oyinkan |e verfasserin |4 aut | |
| 700 | 1 | |a McDonough, Tiffani |e verfasserin |4 aut | |
| 700 | 1 | |a Mikati, Mohamad A |e verfasserin |4 aut | |
| 700 | 1 | |a Morgan, Lindsey |e verfasserin |4 aut | |
| 700 | 1 | |a Novotny, Edward |e verfasserin |4 aut | |
| 700 | 1 | |a Ostendorf, Adam P |e verfasserin |4 aut | |
| 700 | 1 | |a Payne, Eric T |e verfasserin |4 aut | |
| 700 | 1 | |a Piantino, Juan |e verfasserin |4 aut | |
| 700 | 1 | |a Riviello, James |e verfasserin |4 aut | |
| 700 | 1 | |a Sands, Tristan |e verfasserin |4 aut | |
| 700 | 1 | |a Stafstrom, Carl E |e verfasserin |4 aut | |
| 700 | 1 | |a Tasker, Robert C |e verfasserin |4 aut | |
| 700 | 1 | |a Tchapyjnikov, Dmitry |e verfasserin |4 aut | |
| 700 | 1 | |a Vasquez, Alejandra |e verfasserin |4 aut | |
| 700 | 1 | |a Wainwright, Mark S |e verfasserin |4 aut | |
| 700 | 1 | |a Wilfong, Angus |e verfasserin |4 aut | |
| 700 | 1 | |a Williams, Korwyn |e verfasserin |4 aut | |
| 700 | 1 | |a Loddenkemper, Tobias |e verfasserin |4 aut | |
| 700 | 0 | |a for Pediatric Status Epilepticus Research Group (pSERG) |e verfasserin |4 aut | |
| 700 | 1 | |a Bansal, Seema |e investigator |4 oth | |
| 700 | 1 | |a Habela, Christa |e investigator |4 oth | |
| 700 | 1 | |a Lewis, Dalila |e investigator |4 oth | |
| 700 | 1 | |a Sculier, Claudine |e investigator |4 oth | |
| 700 | 1 | |a Sacco, Melissa |e investigator |4 oth | |
| 700 | 1 | |a Santel, Daniel |e investigator |4 oth | |
| 700 | 1 | |a Weber, Amanda |e investigator |4 oth | |
| 700 | 1 | |a Yuliati, Asri |e investigator |4 oth | |
| 700 | 1 | |a Singh, Azara |e investigator |4 oth | |
| 700 | 1 | |a Heath, Ashley |e investigator |4 oth | |
| 700 | 1 | |a Turner, David |e investigator |4 oth | |
| 700 | 1 | |a Fernandes, Cecilia |e investigator |4 oth | |
| 700 | 1 | |a Tran, Linh |e investigator |4 oth | |
| 700 | 1 | |a Farias-Moeller, Raquel |e investigator |4 oth | |
| 700 | 1 | |a Hecox, Kurt |e investigator |4 oth | |
| 700 | 1 | |a Sannagowdara, Kumar |e investigator |4 oth | |
| 700 | 1 | |a Goldstein, David |e investigator |4 oth | |
| 700 | 1 | |a Cox, Erin Heinzen |e investigator |4 oth | |
| 700 | 1 | |a Malone, Colin |e investigator |4 oth | |
| 700 | 1 | |a Topjian, Alexis |e investigator |4 oth | |
| 700 | 1 | |a Hahn, Cecil |e investigator |4 oth | |
| 700 | 1 | |a Ganesan, Saptharishi Rishi Lalgudi |e investigator |4 oth | |
| 700 | 1 | |a Weinstein, Steven |e investigator |4 oth | |
| 700 | 1 | |a Dean, Nathan |e investigator |4 oth | |
| 700 | 1 | |a Shellhaas, Renee |e investigator |4 oth | |
| 700 | 1 | |a Benedetti, Guilia |e investigator |4 oth | |
| 700 | 1 | |a Smith, Garnett |e investigator |4 oth | |
| 700 | 1 | |a Selioutski, Olga |e investigator |4 oth | |
| 700 | 1 | |a Hughes, Inna |e investigator |4 oth | |
| 700 | 1 | |a Seltzer, Lurie |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Neurology |d 1951 |g 101(2023), 5 vom: 01. Aug., Seite e546-e557 |w (DE-627)NLM000034355 |x 1526-632X |7 nnns |
| 773 | 1 | 8 | |g volume:101 |g year:2023 |g number:5 |g day:01 |g month:08 |g pages:e546-e557 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1212/WNL.0000000000207472 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 101 |j 2023 |e 5 |b 01 |c 08 |h e546-e557 | ||